Bronchial aspergillosis after fludarabine therapy;Aspergillose bronchique a A nidulans apres traitement par fludarabine d'un lymphome de bas grade

Revue de Medecine Interne

Volumn 18, Issue 3, 1997, Pages 235-236

  Peyrade, F ^a   Boscagli, A ^a   Roa, M ^a   Taillan, B ^a   Gary Toussain, M ^a   Dujardin, P ^a  

^a University of Côte d'Azur   (France)

Author keywords

aspergillosis; fludarabine

Indexed keywords

AMPHOTERICIN B; FLUDARABINE; ITRACONAZOLE; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; VIDARABINE;

ARTICLE; ASPERGILLOSIS; CASE REPORT; HUMAN; LUNG INFECTION; LYMPHOCYTE COUNT; MALE; NEUTROPENIA; OPPORTUNISTIC INFECTION; BRONCHUS DISEASE; MICROBIOLOGY; NONHODGKIN LYMPHOMA;

ANTINEOPLASTIC AGENTS; ASPERGILLOSIS; BRONCHIAL DISEASES; HUMANS; LYMPHOMA, LOW-GRADE; MALE; VIDARABINE;

EID: 0031105793     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(97)89301-0     Document Type: Article

References (5)

1. 1 Turner-Warwick M. Aspergillus fumigatus and lung disease. Postgrad Med J 1979;55:642-4
2. 2 Mizuki M, Chikuba K, Tanaka K. A case of chronic necrotizing pulmonary aspergillosis due to A nidulans. Mycopathologia 1994;128:75-9
3. 3 Petitjean O, Jacolot A, Tod M. Pharmacologie des antifongiques azolés systémiques. Méd Mal Infect 1995;25:14-26
4. 4 Cheson B. Infectious and immunosuppressive complications of purine analogs therapy. J Clin Oncol 1995;13:2431-48
5. 5 Nahmias A. Comprehensive immunology. In: Immunology of human infection: Bacteriae, Chlamydiae and fungi. Philadelphia: Plenum Medical Book Company, 1981